Tariffs slow LP distributions; tracking public healthcare services valuations; European VC brings resilience

Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch: VC, PE and M&A April 18, 2025 The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data US-first biotech resurgence: How tariff policies are reshaping VC opportunities Protectionist tariff policies are driving an "America-first resurgence" in biotech, creating structural advantages for US companies while potentially suppressing M&A activity. Our latest analyst note identifies premium investment opportunities in AI-driven drug discovery platforms and compact biomanufacturing technologies that address domestic labor costs while offering significant growth potential. Strategic investments and government initiatives will be critical for supply chain resilience, particularly for traditional drug modalities, as tariff policies shift market dynamics to favor American-made pharmaceuticals and increase scrutiny on cross-border licensing. read it now   Share: PitchBook Universities: College decision day approaches Trying to choose a college—or curious how your alma mater stacks up? PitchBook's university rankings compare schools by tallying up the number of alumni entrepreneurs who have raised venture capital in the last decade. Whether you're chasing VC dollars or dreaming up your first pitch deck, these schools have a track record of cultivating future entrepreneurs. The list was last updated in August 2024. explore the rankings   Share:   A message from PitchBook Data   Ready to engage top PE and VC audiences? Our 2025 PitchBook Media Kit offers service providers direct access to 2.1 million engaged professionals through our targeted newsletters and exclusive reports. Backed by PitchBook's trusted global data, our sponsorships amplify your brand via custom reports, asset class insights, website and native content partnerships. See what's new for 2025 Share:   Tariff uproar to further slow distributions to LPs (Brandon Bell/Getty Images) Buyout funds' lifecycles are getting longer and longer, to the chagrin of their investors. President Donald Trump's tariff showdown will not make them any shorter. A standard PE fund has a lifetime of 10 years, meaning it deploys and returns the total capital LPs have invested in it by the time it's a decade old. But, according to a Houlihan Lokey survey of LPs, 51% of respondents have been waiting more than 13 years for their PE funds to fully liquidate, and 12% said they've been waiting over 15 years. read more Share: